Journal
ACTA PAEDIATRICA
Volume 98, Issue 9, Pages 1461-1467Publisher
WILEY
DOI: 10.1111/j.1651-2227.2009.01355.x
Keywords
Allergy; Eczema; Lactation; Polyunsaturated fatty acids; Pregnancy
Categories
Funding
- Medical Research Council of Southeast Sweden (FORSS)
- Ostergotland County Council
- Ekhaga Foundation
- Swedish Asthma and Allergy Association
- Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)
- Swedish Society of Medicine and Glaxo Smith Kline, Sweden
Ask authors/readers for more resources
Maternal intake of omega-3 (-3) polyunsaturated fatty acids (PUFAs) during pregnancy has decreased, possibly contributing to a current increased risk of childhood allergy. Aim: To describe the effects of maternal -3 long-chain PUFA supplementation during pregnancy and lactation on the incidence of allergic disease in infancy. Methods: One hundred and forty-five pregnant women, affected by allergy themselves or having a husband or previous child with allergies, were included in a randomized placebo-controlled trial. Daily maternal supplementation with either 1.6 g eicosapentaenoic acid and 1.1 g docosahexaenoic acid or placebo was given from the 25(th) gestational week to average 3-4 months of breastfeeding. Skin prick tests, detection of circulating specific immunoglobulin E (IgE) antibodies and clinical examinations of the infants were performed. Results: The period prevalence of food allergy was lower in the -3 group (1/52, 2%) compared to the placebo group (10/65, 15%, p < 0.05) as well as the incidence of IgE-associated eczema (-3 group: 4/52, 8%; placebo group: 15/63, 24%, p < 0.05). Conclusion: Maternal -3 fatty acid supplementation may decrease the risk of food allergy and IgE-associated eczema during the first year of life in infants with a family history of allergic disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available